Global (United States, European Union and China) Parkinson's Disease Drug Market Research Report 2019-2025

Global (United States, European Union and China) Parkinson's Disease Drug Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Parkinson's Disease Drug Market Size Growth Rate by Type (2019-2025)
1.3.2 Sinemet-CR
1.3.3 Trastal
1.3.4 Madopar
1.3.5 COMT Inhibitor
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global Parkinson's Disease Drug Market Share by Application (2019-2025)
1.4.2 Under 40 Years Old
1.4.3 40-65 Years Old
1.4.4 Above 65 Years Old
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Drug Market Size
2.1.1 Global Parkinson's Disease Drug Revenue 2014-2025
2.1.2 Global Parkinson's Disease Drug Sales 2014-2025
2.2 Parkinson's Disease Drug Growth Rate by Regions
2.2.1 Global Parkinson's Disease Drug Sales by Regions 2014-2019
2.2.2 Global Parkinson's Disease Drug Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Parkinson's Disease Drug Sales by Manufacturers
3.1.1 Parkinson's Disease Drug Sales by Manufacturers 2014-2019
3.1.2 Parkinson's Disease Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Parkinson's Disease Drug Revenue by Manufacturers (2014-2019)
3.2.2 Parkinson's Disease Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Parkinson's Disease Drug Market Concentration Ratio (CR5 and HHI)
3.3 Parkinson's Disease Drug Price by Manufacturers
3.4 Key Manufacturers Parkinson's Disease Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Parkinson's Disease Drug Market
3.6 Key Manufacturers Parkinson's Disease Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Sinemet-CR Sales and Revenue (2014-2019)
4.1.2 Trastal Sales and Revenue (2014-2019)
4.1.3 Madopar Sales and Revenue (2014-2019)
4.1.4 COMT Inhibitor Sales and Revenue (2014-2019)
4.1.5 Other Sales and Revenue (2014-2019)
4.2 Global Parkinson's Disease Drug Sales Market Share by Type
4.3 Global Parkinson's Disease Drug Revenue Market Share by Type
4.4 Parkinson's Disease Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Parkinson's Disease Drug Sales by Application
6 United States
6.1 United States Parkinson's Disease Drug Breakdown Data by Company
6.2 United States Parkinson's Disease Drug Breakdown Data by Type
6.3 United States Parkinson's Disease Drug Breakdown Data by Application
7 European Union
7.1 European Union Parkinson's Disease Drug Breakdown Data by Company
7.2 European Union Parkinson's Disease Drug Breakdown Data by Type
7.3 European Union Parkinson's Disease Drug Breakdown Data by Application
8 China
8.1 China Parkinson's Disease Drug Breakdown Data by Company
8.2 China Parkinson's Disease Drug Breakdown Data by Type
8.3 China Parkinson's Disease Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Parkinson's Disease Drug Breakdown Data by Company
9.2 Rest of World Parkinson's Disease Drug Breakdown Data by Type
9.3 Rest of World Parkinson's Disease Drug Breakdown Data by Application
9.4 Rest of World Parkinson's Disease Drug Breakdown Data by Countries
9.4.1 Rest of World Parkinson's Disease Drug Sales by Countries
9.4.2 Rest of World Parkinson's Disease Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.1.4 Parkinson's Disease Drug Product Introduction
10.1.5 Merck Recent Development
10.2 Akorn
10.2.1 Akorn Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.2.4 Parkinson's Disease Drug Product Introduction
10.2.5 Akorn Recent Development
10.3 GSK
10.3.1 GSK Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.3.4 Parkinson's Disease Drug Product Introduction
10.3.5 GSK Recent Development
10.4 Novartis
10.4.1 Novartis Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.4.4 Parkinson's Disease Drug Product Introduction
10.4.5 Novartis Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.5.4 Parkinson's Disease Drug Product Introduction
10.5.5 Boehringer Ingelheim Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.6.4 Parkinson's Disease Drug Product Introduction
10.6.5 Teva Pharmaceutical Recent Development
10.7 Abbvie
10.7.1 Abbvie Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.7.4 Parkinson's Disease Drug Product Introduction
10.7.5 Abbvie Recent Development
10.8 Kyowa Hakko Kirin Pharma
10.8.1 Kyowa Hakko Kirin Pharma Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.8.4 Parkinson's Disease Drug Product Introduction
10.8.5 Kyowa Hakko Kirin Pharma Recent Development
10.9 Astellas Pharma
10.9.1 Astellas Pharma Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.9.4 Parkinson's Disease Drug Product Introduction
10.9.5 Astellas Pharma Recent Development
10.10 Desitin Arzneimittel
10.10.1 Desitin Arzneimittel Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
10.10.4 Parkinson's Disease Drug Product Introduction
10.10.5 Desitin Arzneimittel Recent Development
10.11 Endo Pharmaceuticals
10.12 F.Hoffmann-La Roche
10.13 H.Lundbeck
10.14 Valeant
10.15 Apokyn
10.16 Orion
10.17 Stada Arzneimittel
10.18 US WorldMeds
10.19 Valeant Pharmaceuticals
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Parkinson's Disease Drug Sales Channels
11.2.2 Parkinson's Disease Drug Distributors
11.3 Parkinson's Disease Drug Customers
12 Market Forecast
12.1 Global Parkinson's Disease Drug Sales and Revenue Forecast 2019-2025
12.2 Global Parkinson's Disease Drug Sales Forecast by Type
12.3 Global Parkinson's Disease Drug Sales Forecast by Application
12.4 Parkinson's Disease Drug Forecast by Regions
12.4.1 Global Parkinson's Disease Drug Sales Forecast by Regions 2019-2025
12.4.2 Global Parkinson's Disease Drug Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Parkinson's Disease Drug Product Picture
Table Parkinson's Disease Drug Key Market Segments
Table Major Manufacturers Parkinson's Disease Drug Covered in This Report
Table Global Parkinson's Disease Drug Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Parkinson's Disease Drug Sales Market Shar by Type 2014-2025
Figure Sinemet-CR Figures
Table Major Manufacturers of Sinemet-CR
Figure Trastal Figures
Table Major Manufacturers of Trastal
Figure Madopar Figures
Table Major Manufacturers of Madopar
Figure COMT Inhibitor Figures
Table Major Manufacturers of COMT Inhibitor
Figure Other Figures
Table Major Manufacturers of Other
Table Global Parkinson's Disease Drug Market Share by Application 2019-2025 (K Units)
Figure Under 40 Years Old Use Case
Figure 40-65 Years Old Use Case
Figure Above 65 Years Old Use Case
Figure Parkinson's Disease Drug Report Years Considered
Figure Global Parkinson's Disease Drug Market Size 2014-2025 (Million US$)
Figure Global Parkinson's Disease Drug Sales 2014-2019 (K Units)
Table Global Parkinson's Disease Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Parkinson's Disease Drug Sales by Regions 2014-2019 (K Units)
Table Global Parkinson's Disease Drug Sales Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Sales Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Sales Market Share by Regions in 2019
Table Global Parkinson's Disease Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Parkinson's Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Parkinson's Disease Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Parkinson's Disease Drug Sales Share by Manufacturers (2014-2019)
Figure Global Parkinson's Disease Drug Sales Share by Manufacturers in 2019
Table Parkinson's Disease Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Parkinson's Disease Drug Revenue Share by Manufacturers (2014-2019)
Figure Parkinson's Disease Drug Value Share by Manufacturers in 2019
Table Global Parkinson's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Parkinson's Disease Drug Price (2014-2019) (USD/Unit)
Table Key Manufacturers Parkinson's Disease Drug Plants/Factories Distribution
Table Key Manufacturers Parkinson's Disease Drug Area Served
Table Date of Key Manufacturers Enter into Parkinson's Disease Drug Market
Table Key Manufacturers Parkinson's Disease Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Sinemet-CR Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Trastal Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Madopar Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global COMT Inhibitor Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Other Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Parkinson's Disease Drug Sales by Type (2014-2019) (K Units)
Table Global Parkinson's Disease Drug Sales Share by Type (2014-2019)
Figure Global Parkinson's Disease Drug Sales Market Share by Type (2014-2019)
Figure Global Parkinson's Disease Drug Sales Market Share by Type in 2018
Table Global Parkinson's Disease Drug Revenue by Type (2014-2019) (Million US$)
Table Global Parkinson's Disease Drug Revenue Share by Type (2014-2019)
Figure Global Parkinson's Disease Drug Revenue Market Share by Type (2014-2019)
Figure Global Parkinson's Disease Drug Revenue Market Share by Type in 2018
Table Parkinson's Disease Drug Price by Type 2014-2019 (USD/Unit)
Table Global Parkinson's Disease Drug Sales by Application (2014-2019) (K Units)
Table Global Parkinson's Disease Drug Sales Share by Application (2014-2019)
Figure Global Sales Parkinson's Disease Drug Market Share by Application (2014-2019)
Figure Global Sales Parkinson's Disease Drug Market Share by Application (2014-2019)
Figure United States Parkinson's Disease Drug Sales Growth Rate 2014-2019 (K Units)
Figure United States Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table United States Parkinson's Disease Drug Sales by Company (2014-2019) (K Units)
Table United States Parkinson's Disease Drug Sales Market Share by Company (2014-2019)
Figure United States Parkinson's Disease Drug Sales Market Share by Company in 2019
Table United States Parkinson's Disease Drug Sales by Type (2014-2019) (K Units)
Table United States Parkinson's Disease Drug Sales Market Share by Type (2014-2019)
Figure United States Parkinson's Disease Drug Market Share by Type in 2019
Table United States Parkinson's Disease Drug Sales by Application (2014-2019) (K Units)
Table United States Parkinson's Disease Drug Sales Market Share by Application (2014-2019)
Figure United States Parkinson's Disease Drug Market Share by Application in 2019
Figure European Union Parkinson's Disease Drug Sales Growth Rate 2014-2019 (K Units)
Figure European Union Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Parkinson's Disease Drug Sales by Company (2014-2019) (K Units)
Table European Union Parkinson's Disease Drug Sales Market Share by Company (2014-2019)
Figure European Union Parkinson's Disease Drug Sales Market Share by Company in 2019
Table European Union Parkinson's Disease Drug Sales by Type (2014-2019) (K Units)
Table European Union Parkinson's Disease Drug Sales Market Share by Type (2014-2019)
Figure 2018 European Union Parkinson's Disease Drug Market Share by Type
Table European Union Parkinson's Disease Drug Sales by Application (2014-2019) (K Units)
Table European Union Parkinson's Disease Drug Sales Market Share by Application (2014-2019)
Figure 2018 European Union Parkinson's Disease Drug Market Share by Application
Figure China Parkinson's Disease Drug Sales Growth Rate 2014-2019 (K Units)
Figure China Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table China Parkinson's Disease Drug Sales by Company (2014-2019) (K Units)
Table China Parkinson's Disease Drug Sales Market Share by Company (2014-2019)
Figure China Parkinson's Disease Drug Sales Market Share by Company in 2019
Table China Parkinson's Disease Drug Sales by Type (2014-2019) (K Units)
Table China Parkinson's Disease Drug Sales Market Share by Type (2014-2019)
Figure China Parkinson's Disease Drug Market Share by Type in 2019
Table China Parkinson's Disease Drug Sales by Application (2014-2019) (K Units)
Table China Parkinson's Disease Drug Sales Market Share by Application (2014-2019)
Figure China Parkinson's Disease Drug Market Share by Application in 2019
Figure Rest of World Parkinson's Disease Drug Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Parkinson's Disease Drug Sales by Company (2014-2019) (K Units)
Table Rest of World Parkinson's Disease Drug Sales Market Share by Company (2014-2019)
Figure Rest of World Parkinson's Disease Drug Sales Market Share by Company in 2019
Table Rest of World Parkinson's Disease Drug Sales by Type (2014-2019) (K Units)
Table Rest of World Parkinson's Disease Drug Sales Market Share by Type (2014-2019)
Figure Rest of World Parkinson's Disease Drug Market Share by Type in 2019
Table Rest of World Parkinson's Disease Drug Sales by Application (2014-2019) (K Units)
Table Rest of World Parkinson's Disease Drug Sales Market Share by Application (2014-2019)
Figure Rest of World Parkinson's Disease Drug Market Share by Application in 2019
Table Rest of World Parkinson's Disease Drug Sales by Countries (2014-2019) (K Units)
Table Rest of World Parkinson's Disease Drug Sales Market Share by Countries (2014-2019)
Figure Rest of World Parkinson's Disease Drug Sales Market Share by Countries in 2019
Table Rest of World Parkinson's Disease Drug Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Parkinson's Disease Drug Revenue Market Share by Countries (2014-2019)
Figure Rest of World Parkinson's Disease Drug Revenue Market Share by Countries in 2019
Figure Japan Parkinson's Disease Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Parkinson's Disease Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Parkinson's Disease Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Parkinson's Disease Drug Revenue Growth Rate (2014-2019) (K Units)
Figure India Parkinson's Disease Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Parkinson's Disease Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Parkinson's Disease Drug Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Parkinson's Disease Drug Revenue Growth Rate (2014-2019) (K Units)
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Merck Parkinson's Disease Drug Sales Market Share in Global Market
Table Merck Recent Development
Table Akorn Company Details
Table Akorn Description and Business Overview
Table Akorn Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Akorn Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Akorn Parkinson's Disease Drug Sales Market Share in Global Market
Table Akorn Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table GSK Parkinson's Disease Drug Sales Market Share in Global Market
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Novartis Parkinson's Disease Drug Sales Market Share in Global Market
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Description and Business Overview
Table Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Sales Market Share in Global Market
Table Teva Pharmaceutical Recent Development
Table Abbvie Company Details
Table Abbvie Description and Business Overview
Table Abbvie Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbvie Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Abbvie Parkinson's Disease Drug Sales Market Share in Global Market
Table Abbvie Recent Development
Table Kyowa Hakko Kirin Pharma Company Details
Table Kyowa Hakko Kirin Pharma Description and Business Overview
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Market Share in Global Market
Table Kyowa Hakko Kirin Pharma Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Description and Business Overview
Table Astellas Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Sales Market Share in Global Market
Table Astellas Pharma Recent Development
Table Desitin Arzneimittel Company Details
Table Desitin Arzneimittel Description and Business Overview
Table Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Sales Growth Rate (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Sales Market Share in Global Market
Table Desitin Arzneimittel Recent Development
Table Endo Pharmaceuticals Company Details
Table F.Hoffmann-La Roche Company Details
Table H.Lundbeck Company Details
Table Valeant Company Details
Table Apokyn Company Details
Table Orion Company Details
Table Stada Arzneimittel Company Details
Table US WorldMeds Company Details
Table Valeant Pharmaceuticals Company Details
Figure Parkinson's Disease Drug Value Chain
Table Parkinson's Disease Drug Distributors List
Table Parkinson's Disease Drug Customers List
Table Global Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Parkinson's Disease Drug Sales Forecast by Type 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Sales Forecast by Type 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Sales Market Share Forecast by Type 2019-2025
Table Global Parkinson's Disease Drug Sales Forecast by Application 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Sales Forecast by Application 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Sales Market Share Forecast by Application 2019-2025
Table Global Parkinson's Disease Drug Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Parkinson's Disease Drug Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Parkinson's Disease Drug Revenue Market Share Forecast by Regions 2019-2025
Figure United States Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure United States Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Figure European Union Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure European Union Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Figure China Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure China Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Figure Japan Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure Japan Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Figure Korea Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure Korea Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Figure India Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure India Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Parkinson's Disease Drug Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Parkinson's Disease Drug Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs